StockData
Iambic Therapeutics, Inc. logo

Iambic Therapeutics, Inc. (IAM) KPIs and segments

IAMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$14.76+0.54 (+3.80%)

Close on Nov 18, 2026Market cap –P/E –Yield –

KPIs & segments

Operating metrics and segments that drive Iambic Therapeutics's business

Coming soon

This tab will track the numbers specific to Iambic Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?